We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$3.01B
AUM Growth
-$95.8M
Cap. Flow
-$186M
Cap. Flow %
-6.17%
Top 10 Hldgs %
20.69%
Holding
309
New
19
Increased
61
Reduced
173
Closed
36

Sector Composition

Rank Sector Weight
1 Healthcare 22.55%
2 Industrials 20.61%
3 Technology 18.89%
4 Consumer Discretionary 10.17%
5 Communication Services 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRA icon
1
Strategic Education
STRA
$1.87B
$90M 2.99%
505,730
-78,675
-13% -$12.9M
PINC
2
DELISTED
Premier
PINC
$80.2M 2.67%
2,051,802
-127,735
-6% -$4.61M
TTD icon
3
Trade Desk
TTD
$8.4B
$65.7M 2.18%
2,882,890
-459,470
-14% -$9.88M
WIX icon
4
WIX.com
WIX
$2.18B
$65.3M 2.17%
459,398
-55,926
-11% -$7.55M
POOL icon
5
Pool Corp
POOL
$6.77B
$58.9M 1.96%
308,203
-15,719
-5% -$2.84M
EBS icon
6
Emergent Biosolutions
EBS
$365M
$58.1M 1.93%
1,203,666
-16,788
-1% -$805K
TFX icon
7
Teleflex
TFX
$5.8B
$55.8M 1.85%
168,417
-10,637
-6% -$3.21M
SMTC icon
8
Semtech
SMTC
$11.1B
$52.1M 1.73%
1,083,295
-130,332
-11% -$6.33M
WNS
9
DELISTED
WNS Holdings
WNS
$48.4M 1.61%
817,071
-39,589
-5% -$2.22M
ZD icon
10
Ziff Davis
ZD
$1.92B
$48.2M 1.6%
624,210
-38,533
-6% -$2.91M
NGVT icon
11
Ingevity
NGVT
$2.48B
$46.6M 1.55%
443,291
+83,987
+23% +$8.44M
SFLY
12
DELISTED
Shutterfly, Inc.
SFLY
$46.3M 1.54%
915,034
-37,257
-4% -$1.7M
LCII icon
13
LCI Industries
LCII
$2.46B
$45.7M 1.52%
508,067
-32,931
-6% -$2.91M
SUPN icon
14
Supernus Pharmaceuticals
SUPN
$2.6B
$44.7M 1.49%
1,351,286
+350,905
+35% +$12M
PLAY icon
15
Dave & Buster's
PLAY
$375M
$44.2M 1.47%
1,091,424
-333,727
-23% -$17M
CY
16
DELISTED
Cypress Semiconductor
CY
$40M 1.33%
1,796,427
-1,214,957
-40% -$22M
LGND icon
17
Ligand Pharmaceuticals
LGND
$5.84B
$36.8M 1.22%
516,559
-31,893
-6% -$2.35M
DOOR
18
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$36.8M 1.22%
697,764
-7,489
-1% -$387K
MMS icon
19
Maximus
MMS
$3.16B
$35.7M 1.19%
491,980
-29,897
-6% -$2.17M
MDSO
20
DELISTED
Medidata Solutions, Inc.
MDSO
$35.6M 1.18%
392,849
-20,875
-5% -$1.83M
MTN icon
21
Vail Resorts
MTN
$5.38B
$35.3M 1.17%
158,314
-8,524
-5% -$1.89M
EEFT icon
22
Euronet Worldwide
EEFT
$2.77B
$34.5M 1.15%
205,061
-21,973
-10% -$3.36M
AX icon
23
Axos Financial
AX
$5.7B
$33.6M 1.12%
1,231,911
-55,021
-4% -$1.62M
ON icon
24
ON Semiconductor
ON
$32.6B
$33.4M 1.11%
1,650,855
-191,916
-10% -$3.97M
CEVA icon
25
CEVA Inc
CEVA
$909M
$31.1M 1.03%
1,277,509
-9,464
-0.7% -$232K

Similar funds

Rice Hall James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Rice Hall James & Associates held 309 positions worth $3.01B, down 3.1% from $3.11B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Rice Hall James & Associates withdrew a net $186M in Q2 2019, closing 36 positions and reducing 173 holdings. Its most notable exit was Globus Medical, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Rice Hall James & Associates opened a new position in Armstrong World Industries worth $26.7M.

  • Rice Hall James & Associates's largest Q2 2019 buy was Armstrong World Industries: 274,237 shares worth $26.7M.
  • Rice Hall James & Associates added most to PGT, Inc. in Q2 2019, an estimated $13M increase.
  • Rice Hall James & Associates's biggest Q2 2019 reduction was Tetra Tech, cutting an estimated $34.1M.
  • Rice Hall James & Associates fully exited Globus Medical in Q2 2019, selling an estimated $15.4M.
  • Rice Hall James & Associates's ten largest holdings make up 21% of its $3.01B portfolio in Q2 2019.
  • Rice Hall James & Associates opened 19 new positions and closed 36 in Q2 2019.
  • Rice Hall James & Associates's portfolio value fell 3.1% quarter-over-quarter to $3.01B.

Based on Rice Hall James & Associates's 13F filing for Q2 2019, filed 1 Aug 2019.